Category Archives: – Biotech

How to beat the virus with early treatment

Posted on January 25, 2023 by admin

July 22, 2021- by Steven E. Greer, MD I woke up yesterday with a slight malaise and I sneezed once. I knew I had come down with a virus

Posted in - Biotech, - Generics, - Opinion, - Pharma, - Policy, Duke, Emergency medicine, Geriatrics, Infectious disease, Internal Medicine, Pediatrics, Primary care medicine, Pulmonology | Leave a comment

The only thing we have to fear…is fear itself

Posted on January 13, 2023 by admin

March 13, 2020- by Steven E. Greer, MD Holy cow. The PGA Tour cancelled the Players Championship due to fears over the coronavirus.

Posted in - Biotech, - Medical Devices, - Opinion, - Pharma, - Policy, CDC, CMS, Congress, Emergency medicine, FDA, Infectious disease, Internal Medicine, NIH, Primary care medicine, Pulmonology, VA | Leave a comment

Pfizer documents show vaccine causes high fetal death rates

Posted on September 3, 2022 by admin

February 3, 2022- by Steven E. Greer, MD

Posted in - Biotech, - Pharma, FDA, Infectious disease, Internal Medicine, NIH, Obstetrics and Gynecology, Pediatrics | Leave a comment

India, Mexico, and El Salvador distribute ivermectin to citizens in free COVID kits

Posted on February 20, 2022 by admin

January 20, 2022- by Steven E. Greer, MD As all hospitals in the U.S. refuse to administer lifesaving early treatments for the SARS-CoV-2 coronavirus,

Posted in - Biotech, - Generics, - Medical Devices, - Pharma, - Policy, Infectious disease, Internal Medicine | Leave a comment

What you need to know about the SARS-CoV-2 coronavirus vaccines

Posted on May 7, 2021 by admin

Update March 22, 2021- by Steven E. Greer, MD Tucker Carlson interviewed a surgeon who stated what I have known for many months. The signal

Posted in - Biotech, - Opinion, - Pharma, - Policy, CDC, Congress, FDA, Infectious disease, Internal Medicine, NIH | Leave a comment

Sen. Ron Johnson on the need for early treatment of the Wuhan coronavirus

Posted on March 19, 2021 by admin

December 13, 2020- by Steven E. Greer, MD This is straight from my book, Tony’s Virus, chapters 8 and chapter 10.

Posted in - Biotech, - Generics, - Opinion, - Pharma, - Policy, CDC, CMS, Congress, FDA, NIH | Leave a comment

The “surge in new Wuhan virus cases” is great news

Posted on July 19, 2020 by admin

June 26, 2020- by Steven E. Greer, MD I called it, once again. On June 9th, I wrote, “This unprecedented communist-party-like anarchy in

Posted in - Biotech, - Opinion, - Pharma, - Policy, Emergency medicine, Infectious disease, Internal Medicine, Pediatrics, Primary care medicine, Pulmonology | 2 Comments

Are there any medications to treat coronavirus?

Posted on March 21, 2020 by admin

(Also: How infectious and lethal is this Coronavirus COVID-19 compared to regular “flu”?) February 27, 2020- by Steven E. Greer, MD Gilead makes a not-yet-approved antiviral drug called remdisivir and it is being tested right

Posted in - Biotech, - Opinion, - Pharma, - Policy, CDC, Congress, FDA, Geriatrics, Infectious disease, Internal Medicine, NIH, Primary care medicine | 2 Comments

60 Minutes creates another publicist-paid puff-piece for an unethical medical researcher

Posted on February 1, 2020 by admin

December 8, 2019- by Steven E. Greer, MD CBS’ 60 Minutes featured an extremely unethical PhD medical researcher at Harvard named George

Posted in - Biotech, - Opinion, - Pharma, - Policy, CDC, Congress, FDA, Genetics, NIH | Leave a comment

Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma

Posted on January 9, 2020 by admin

February 27, 2017- interviewed by Steven E. Greer, MD We interviewed Joaquim Bellmunt, MD, PhD, the Director of the Bladder Cancer Center at Dana-Farber,

Posted in - Biotech, - NEJM, - Pharma, Harvard, Oncology | Leave a comment

Preventing HIV infection

Posted on January 9, 2020 by admin

July 28, 2014- Interviewed by Steven E. Greer, MD Rajesh Tim Gandhi, MD of the Massachusetts General Hospital discusses the NEJM review paper he co-wrote

Posted in - Biotech, - NEJM, - Pharma, General surgery, Harvard, Infectious disease, Primary care medicine | Leave a comment

Paul Richardson, MD: Current Therapies for Multiple Myeloma

Posted on January 7, 2020 by admin

December 15, 2015- Interviewed by Steven Greer, MD Dr. Paul Richardson, Clinical Director of the Multiple Myeloma Center at Harvard’s Dana-Farber

Posted in - Biotech, - Pharma, Harvard, Oncology | Leave a comment

Triple Therapy for Cystic Fibrosis

Posted on December 12, 2019 by admin

October 18, 2018- interviewed by Steven E. Greer, MD

Posted in - Biotech, - NEJM, - Pharma, FDA, Genetics, Infectious disease, Internal Medicine, National Jewish Health, Pediatrics, Pulmonology | Leave a comment

BRAF and MEK combos for melanoma

Posted on September 18, 2019 by admin

Update October 1, 2015- The FDA approved the use of two drugs, Opdivo and Yervoy, to treat metastatic melanoma, as we first discussed with Dr. Ribas last year.

Posted in - Biotech, - Pharma, Oncology, UCLA | Leave a comment

Google wants your medical records

Posted on March 24, 2019 by admin

December 19, 2013- Interviewed by Steven E. Greer, MD In Part 3 of our interview with Robert Klitzman, MD, ethics professor at Columbia University,

Posted in - Biotech, - Policy, Columbia, FDA, Genetics | Leave a comment

Google’s Larry Page wants your medical records to be public for “research”

Posted on March 24, 2019 by admin

March 20, 2014-By Steven E. Greer, MD Charlie Rose interviewed Google founder Larry Page at the 2014 TED conference. During the talk, Mr.

Posted in - Biotech, - Medical Devices, - Opinion, Congress, Genetics | Leave a comment

Review of immunotherapy and targeted therapy

Posted on January 5, 2019 by admin

June 17, 2016- interviewed by Steven E. Greer, MD We interviewed Siwen Hu-Lieskovan MD, PhD of UCLA, an expert with immunotherapies for melanoma, to go over the

Posted in - Biotech, - Pharma, Oncology, UCLA | Leave a comment